ALX Oncology Holdings Inc. ALXO
1.36 USD +0.07 (+5.43%)
At closeNov 4, 2026, 4:02 PM EST
1.36 0.00 0.00%
After hours · Nov 4, 4:02 PM ET
1.32 Day range 1.40
0.862 52-week range 2.66
- YTD
- +20.35%
- 1 year
- -6.85%
Analyst view
Consensus: buy
Buy
Price target (mean) 7.67 +463.7% upside
Now 1.36
- Target (low)
- 2.00
- Target (mean)
- 7.67
- Target (high)
- 25.00
Ratings (0m) 7 4 buy · 3 hold · 0 sell
- Strong buy2
- Buy2
- Hold3
- Sell0
- Strong sell0
Recommendation trend
- This month 7
- 1 month ago 7
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.38766 | -0.38766 – -0.38766 | -0.7896 | +50.9% | 0 | 0.0% | 1 |
| Next quarter | -0.82 | -0.82 – -0.82 | -0.7086 | -15.7% | 0 | 0.0% | 1 |
| Current year | -1.70 | -1.70 – -1.70 | -3.12 | +45.4% | 0 | 0.0% | 1 |
| Next year | -2.28 | -2.81 – -1.75 | -1.70 | -33.8% | 0 | 0.0% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 19, 2024 | Jefferies | Downgrade | Buy | Hold |
| Dec 18, 2024 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Dec 18, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 12, 2024 | Cantor Fitzgerald | Reiterated | — | Overweight |
| Aug 16, 2024 | UBS | Maintained | Buy | Buy |
| Aug 13, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 12, 2024 | Cantor Fitzgerald | Reiterated | — | Overweight |
| Aug 9, 2024 | Stifel | Reiterated | Hold | Hold |
| Aug 1, 2024 | Stifel | Maintained | Hold | Hold |
| Aug 1, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 10, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 29, 2024 | Cantor Fitzgerald | Reiterated | — | Overweight |
| Apr 12, 2024 | Cantor Fitzgerald | Reiterated | — | Overweight |
| Apr 10, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 11, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 8, 2024 | Piper Sandler | Maintained | Overweight | Overweight |
| Mar 8, 2024 | Stifel | Downgrade | Buy | Hold |
| Dec 8, 2023 | Jefferies | Upgrade | Hold | Buy |
| Nov 14, 2023 | Stifel | Maintained | Buy | Buy |
| Oct 11, 2023 | Piper Sandler | Maintained | Overweight | Overweight |
| Oct 4, 2023 | UBS | Maintained | Buy | Buy |
| Oct 4, 2023 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Oct 3, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 12, 2023 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Aug 14, 2023 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Aug 11, 2023 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Aug 11, 2023 | Piper Sandler | Maintained | Overweight | Overweight |
| Aug 11, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jul 24, 2023 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| May 12, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |